Cargando…

The outcome of COVID-19 in patients with hematological malignancy

OBJECTIVE: The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall survival, and to determine the factors affecting mortality. METHODS: This retrospective study included 77 patients with hematological cancer and COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tığlıoğlu, Pınar, Albayrak, Murat, Tığlıoğlu, Mesut, Öztürk, Hacer Berna Afacan, Aras, Merih Reis, Sağlam, Buğra, Maral, Senem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655323/ https://www.ncbi.nlm.nih.gov/pubmed/34904019 http://dx.doi.org/10.1007/s12254-021-00775-5

Ejemplares similares

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
por: YILMAZ, Fatma, et al.
Publicado: (2021)

THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
por: YILMAZ, Fatma, et al.
Publicado: (2021)

DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
por: YILMAZ, Fatma, et al.
Publicado: (2021)

A rare case of pulmonary lymphomatoid granulomatosis complicated with venous thrombosis
por: Maral, Senem, et al.
Publicado: (2021)

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura
por: Malkan, Umit Yavuz, et al.
Publicado: (2020)

R-IDARAM treatment in central nervous system lymphomas: A single-center experience and review of the literature
por: Maral, Senem, et al.
Publicado: (2020)

Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study
por: Sayin, Selim, et al.
Publicado: (2023)

Effect of Blood Groups on Clinical Presentations and Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura Patients with Severe ADAMTS13 Deficiency: A Multi-Center Experience
por: Yıldırım, Murat, et al.
Publicado: (2022)

Co-occurence of follicular lymphoma and Langerhans cell histiocytosis with primary parotid gland involvement: a case report
por: Albayrak, Aynur, et al.
Publicado: (2023)

Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study
por: Acar, Ibrahim Halil, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
por: Civriz Bozdağ, Sinem, et al.
Publicado: (2022)

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies
por: Yağcı, Münci, et al.
Publicado: (2015)

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India
por: Jain, Arihant, et al.
Publicado: (2022)

Risk factors and outcome of COVID-19 in patients with hematological malignancies
por: Piñana, José Luis, et al.
Publicado: (2020)

Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
por: Citterio, Chiara, et al.
Publicado: (2021)

Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19
por: Cook, Michael Roderick, et al.
Publicado: (2020)

Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
por: Cook, Michael R., et al.
Publicado: (2022)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Mammary tuberculosis – importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature
por: Akçay, Müfide Nuran, et al.
Publicado: (2007)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

The Relationship Between Hematological Malignancy and Lipid Profile
por: Ozturk, Erman
Publicado: (2021)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

COVID-19 in Hematologic Malignancies: Big Challenges
por: Hu, Yongxian, et al.
Publicado: (2020)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19
por: Levi, Marcel
Publicado: (2021)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
por: Borah, Pronamee, et al.
Publicado: (2021)

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
por: Ghandili, Susanne, et al.
Publicado: (2021)

Clinical Outcomes of COVID-19 in Hematological Malignancies in Jordan : Tertiary Cancer Center Experience
por: Ababneh, Hazim, et al.
Publicado: (2021)

Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
por: Assi, Tarek, et al.
Publicado: (2020)

COVID-19 and Hematologic Malignancies: Single Institution Analysis
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Intensive care unit outcomes in patients with hematological malignancy
por: Rawson, Jarrod Leigh, et al.
Publicado: (2020)

The importance of genomic predictors for clinical outcome of hematological malignancies
por: Chen, Cunte, et al.
Publicado: (2021)

Outcome Prediction of Hematologic Malignancy in Critically Sick People
por: Velmurugan, Palanivel, et al.
Publicado: (2022)

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

“Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan”
por: Zaki, Adeeba, et al.
Publicado: (2022)

CLL-393 Outcomes of COVID-19 Infections in Patients With Hematological Malignancies in Republic of North Macedonia
por: Cvetanoski, Milche, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iimkqaipvogi56snhb1tdpecg6